Skip to content

Anticholinergic and sedative drug use and functional status among older Australians.

Can medication review using the drug burden index improve function in older Australians?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000018314
Enrollment
115
Registered
2008-01-14
Start date
2008-02-29
Completion date
2009-03-10
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The proposed study will provide important insight for identifying medications that may contribute to functional impairments and age related disability in older Australians. This study aims to describe the exposure of older Australians to medications with sedative and anticholinergic effects using the Drug Burden Index. It will investigate the role of the drug burden index as a tool to guide prescribing in older Australians and whether changes drug burden are associated with changes in the physical and cognitive functional status.

Interventions

Drug burden index is a tool used to quantify a person’s total exposure to anticholinergic and sedative medications. Drug burden index has been associated with physical and cognitive performance in older people. Drug burden index can be used to assess the risks and benefits of prescribing for older populations. This project aims to test the validity of the drug burden index and its association with functional outcomes in an Australian population of older people living in retirement villages. It

Drug burden index is a tool used to quantify a person’s total exposure to anticholinergic and sedative medications. Drug burden index has been associated with physical and cognitive performance in older people. Drug burden index can be used to assess the risks and benefits of prescribing for older populations. This project aims to test the validity of the drug burden index and its association with functional outcomes in an Australian population of older people living in retirement villages. It will also assess the feasibility of drug burden index as a prompt for medication review. The intervention will be conducted over 3 months and it will involve prompting General Practitioners to reduce those drugs contributing to drug burden index and potentially impairing the patient’s physical and cognitive function. For the intervention group, a report including list of medications associated with drug burden index will be sent to the General Practitioner for consideration of possible withdrawal (dose reduction or cessation). The report will quantify the degree of functional impairment that may be associated with the participant's drug burden. For the control group, there will be no prompting about drug burden.

Sponsors

Geoff & Elaine Penney Aged Care Trust Fund
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
70 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

People aged > 70 years who consult their general practitioners regularly who live in the participating retirement villages in Sydney, Australia.

Exclusion criteria

Unable to obtain informed consent from resident or legal caregiver.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026